The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 338:624-626 February 26, 1998 Number 9
NextNext

Treatment of Cystoid Macular Edema with Octreotide

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: Idiopathic cystoid macular edema is an uncommon form of retinal edema that is refractory to treatment with drugs such as acetazolamide1 that are used in patients with other types of macular edema.2,3 We describe the beneficial effect of octreotide in a patient with this disorder.

A 21-year-old man was found to have moderate color-vision defects at routine examination. One year later, he noticed blurred vision. His visual acuity was 20/50 in the right eye and 20/40 in the left eye (Snellen chart). Because he had bilateral cystoid macular edema, he was treated with diclofenac eye drops, peribulbar . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.